Clinical Trial Update: Impact of Fructose Consumption on Intestinal Permeability in Non-alcoholic Fatty Liver Disease (NAFLD) - a Pilot Study. [NA]

View source ↗

Summary

A pilot clinical trial investigates how fructose intake affects intestinal permeability in people with non-alcoholic fatty liver disease and non-alcoholic steat…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Non-alcoholic Fatty Liver Disease
• Non-alcoholic Steatohepatitis

Snippet

Sponsor: Medical University of Vienna | Conditions: Non-alcoholic Fatty Liver Disease, Non-alcoholic Steatohepatitis | NA | Status: COMPLETED